VolitionRx Ltd (VNRX) stock
VNRXNYSEIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$0.16−0.00 (-1.58%)
Close on Nov 20, 2026Market cap $2.21MP/E –Yield –
VolitionRx free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
VolitionRx's free cash flow for the twelve months ending Jun 30, 2026 was -$19.58M. For fiscal 2025 it was -$19.77M. The highest annual figure on record is -$1.69M in fiscal 2011.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$19.77M | – |
| FY2024 | Dec 31, 2024 | -$26.17M | – |
| FY2023 | Dec 31, 2023 | -$19.15M | – |
| FY2022 | Dec 31, 2022 | -$16.85M | – |
| FY2021 | Dec 31, 2021 | -$21.83M | – |
| FY2020 | Dec 31, 2020 | -$18.41M | – |
| FY2019 | Dec 31, 2019 | -$13.25M | – |
| FY2018 | Dec 31, 2018 | -$14.43M | – |
| FY2017 | Dec 31, 2017 | -$13.62M | – |
| FY2016 | Dec 31, 2016 | -$9.28M | – |
| FY2015 | Dec 31, 2015 | -$8.62M | – |
| FY2014 | Dec 31, 2014 | -$4.44M | – |
| FY2013 | Dec 31, 2013 | -$3.08M | – |
| FY2012 | Dec 31, 2012 | -$2.41M | – |
| FY2011 | Dec 31, 2011 | -$1.69M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$5.16M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.29M | – |
| Q4 FY2025 | Dec 31, 2025 | -$5.50M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.63M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.30M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.50M | -189.7% |
| Q3 FY2024 | Sep 30, 2024 | -$5.52M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.77M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.37M | – |
| Q4 FY2023 | Dec 31, 2023 | $6.14M | – |
| Q3 FY2023 | Sep 30, 2023 | -$8.69M | – |
| Q2 FY2023 | Jun 30, 2023 | -$7.65M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.95M | -356.6% |
| Q4 FY2022 | Dec 31, 2022 | -$6.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.14M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.81M | – |
| Q1 FY2022 | Mar 31, 2022 | $3.49M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.54M | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.02M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.62M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.65M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.00M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.58M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.70M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.13M | – |
| Q4 FY2019 | Dec 31, 2019 | -$2.75M | – |
| Q3 FY2019 | Sep 30, 2019 | -$4.31M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.65M | – |
| Q1 FY2019 | Mar 31, 2019 | -$3.54M | – |
| Q4 FY2018 | Dec 31, 2018 | -$3.51M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.56M | – |
| Q2 FY2018 | Jun 30, 2018 | -$2.80M | – |
| Q1 FY2018 | Mar 31, 2018 | -$3.57M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.97M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.93M | – |
| Q2 FY2017 | Jun 30, 2017 | -$3.17M | – |
| Q1 FY2017 | Mar 31, 2017 | -$3.54M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.52M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.14M | – |
See a number that looks wrong?